Induction of cross‐neutralizing antibodies by sequential immunization with heterologous papillomavirus L1VLPs and its implications for HPV prophylactic vaccines-Reference-Cited by-同舟云学术

Induction of cross‐neutralizing antibodies by sequential immunization with heterologous papillomavirus L1VLPs and its implications for HPV prophylactic vaccines

Published:2020-02-19 Issue:12 Volume:92 Page:3750-3758
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:Journal of Medical Virology

Author:

Zhang Ting¹^ORCID,Chen Xue¹,Liao Guoyang²,Hu Meili¹,Xu Jianqing³,Xu Xuemei¹

Affiliation:

1. Department of Biophysics and Structural Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences School of Basic Medicine Peking Union Medical College Beijing China

2. The Fifth Department of Biological Products, Institute of Medical Biology, Chinese Academy of Medical Science Peking Union Medical College Yunnan China

3. Department of Scientific Research, Shanghai Public Health Clinical Center, Institutes of Biomedical Sciences Fudan University Shanghai China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.25690

Reference45 articles.

1. Sequential Immunization with V3 Peptides from Primary Human Immunodeficiency Virus Type 1 Produces Cross-Neutralizing Antibodies against Primary Isolates with a Matching Narrow-Neutralization Sequence Motif

2. Sequential immunizations with rgp120s from independent isolates of human immunodeficiency virus type 1 induce the preferential expansion of broadly crossreactive B cells.